Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Analgesia After Thoracoscopic Lung Cancer Resection
ChiCTR2200060661Phase 2Recruiting
- Sponsor
- Army Medical Center of PLA
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ropivacaine in bronchial carcinoma (4 arms), sponsored by Army Medical Center of PLA. Primary endpoints: Pain Visual Scale Score and Postoperative complications. Started Apr 2022; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2200060661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060661.